These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35685407)

  • 1. Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT
    Yu Q; Zhu D; Zou Y; Wang K; Rao P; Shen Y
    Front Med (Lausanne); 2022; 9():878601. PubMed ID: 35685407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
    Zhou XM; Wang GL; Wang XB; Liu L; Zhang Q; Yin Y; Wang QY; Kang J; Hou G
    Front Pharmacol; 2017; 8():904. PubMed ID: 29311918
    [No Abstract]   [Full Text] [Related]  

  • 6. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
    Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M
    Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
    J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
    Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-β1-induced epithelial-mesenchymal transition through ERK pathway.
    Wang L; Zhang P; Li X; Zhang Y; Zhan Q; Wang C
    Am J Transl Res; 2019; 11(4):2590-2602. PubMed ID: 31105865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
    Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
    Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
    Ba YD; Sun JH; Zhao XX
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways.
    Park SJ; Kim TH; Lee K; Kang MA; Jang HJ; Ryu HW; Oh SR; Lee HJ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells.
    Shao M; Wen ZB; Yang HH; Zhang CY; Xiong JB; Guan XX; Zhong WJ; Jiang HL; Sun CC; Luo XQ; He XF; Zhou Y; Guan CX
    Biomed Pharmacother; 2019 Sep; 117():109193. PubMed ID: 31387171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway.
    Liu YL; Chen BY; Nie J; Zhao GH; Zhuo JY; Yuan J; Li YC; Wang LL; Chen ZW
    Exp Ther Med; 2020 Nov; 20(5):62. PubMed ID: 32952652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalpol Alleviates Ang II-Induced Renal Injury Through NF-κB Pathway and TGF-β1/Smads Pathway.
    Cong C; Yuan X; Hu Y; Chen W; Wang Y; Tao L
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e116-e121. PubMed ID: 34654783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicological study: EZY-1 with potent therapeutic effects of idiopathic pulmonary fibrosis and its mechanisms.
    Wu J; Huang H; Tu M; Yu H; Wei T; Huang X; Jia Y; Mo T; Li Y; Zhang H
    J Food Biochem; 2022 Dec; 46(12):e14483. PubMed ID: 36226766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.